Gemcitabine alters the proteasome composition and immunopeptidome of tumour cells
Gravett, A. M., Stevanović, S., Dalgleish, A. G., Copier, J.
Published in Oncoimmunology (03.06.2018)
Published in Oncoimmunology (03.06.2018)
Get full text
Journal Article
Phase I Study of an Immunomodulatory Thalidomide Analog, CC-4047, in Relapsed or Refractory Multiple Myeloma
SCHEY, S. A, FIELDS, P, BARTLETT, J. B, CLARKE, I. A, ASHAN, G, KNIGHT, R. D, STREETLY, M, DALGLEISH, A. G
Published in Journal of clinical oncology (15.08.2004)
Published in Journal of clinical oncology (15.08.2004)
Get full text
Journal Article
Anti-tumour activity of afatinib, an irreversible ErbB family blocker, in human pancreatic tumour cells
Ioannou, N, Dalgleish, A G, Seddon, A M, Mackintosh, D, Guertler, U, Solca, F, Modjtahedi, H
Published in British journal of cancer (08.11.2011)
Published in British journal of cancer (08.11.2011)
Get full text
Journal Article
Novel thalidomide analogues display anti-angiogenic activity independently of immunomodulatory effects
DREDGE, K, MARRIOTT, J. B, MACDONALD, C. D, MAN, H-W, CHEN, R, MULLER, G. W, STIRLING, D, DALGLEISH, A. G
Published in British journal of cancer (04.11.2002)
Published in British journal of cancer (04.11.2002)
Get full text
Journal Article
Review article: immune suppression and colorectal cancer
EVANS, C., DALGLEISH, A. G., KUMAR, D.
Published in Alimentary pharmacology & therapeutics (15.10.2006)
Published in Alimentary pharmacology & therapeutics (15.10.2006)
Get full text
Journal Article
Phase I study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced cancers
BARTLETT, J. B, MICHAE, A, ZELDIS, J, DALGLEISH, A. G, CLARKE, I. A, DREDGE, K, NICHOLSON, S, KRISTELEIT, H, POLYCHRONIS, A, PANDHA, H, MULLER, G. W, STIRLING, Dl
Published in British journal of cancer (08.03.2004)
Published in British journal of cancer (08.03.2004)
Get full text
Journal Article
Improving the efficacy of cancer immunotherapy
Copier, J, Dalgleish, A.G, Britten, C.M, Finke, L.H, Gaudernack, G, Gnjatic, S, Kallen, K, Kiessling, R, Schuessler-Lenz, M, Singh, H, Talmadge, J, Zwierzina, H, Håkansson, L
Published in European Journal of Cancer (01.05.2009)
Published in European Journal of Cancer (01.05.2009)
Get full text
Journal Article
Thalidomide and its analogues have distinct and opposing effects on TNF‐α and TNFR2 during co‐stimulation of both CD4+ and CD8+ T cells
MARRIOTT, J. B., CLARKE, I. A., DREDGE, K., MULLER, G., STIRLING, D., DALGLEISH, A. G.
Published in Clinical and experimental immunology (01.10.2002)
Published in Clinical and experimental immunology (01.10.2002)
Get full text
Journal Article
Treatment patterns, outcomes, and resource utilization of patients with metastatic melanoma in the U.K.: the MELODY study
Lorigan, P., Marples, M., Harries, M., Wagstaff, J., Dalgleish, A.G., Osborne, R., Maraveyas, A., Nicholson, S., Davidson, N., Wang, Q., Pericleous, L., Bapat, U., Middleton, M.R.
Published in British journal of dermatology (1951) (01.01.2014)
Published in British journal of dermatology (1951) (01.01.2014)
Get full text
Journal Article
Lenalidomide enhances the anti-prostate cancer activity of docetaxel in vitro and in vivo
Henry, J.Y., Lu, L., Adams, M., Meyer, B., Bartlett, J.B., Dalgleish, A.G., Galustian, C.
Published in The Prostate (01.06.2012)
Published in The Prostate (01.06.2012)
Get full text
Journal Article
Supernatants derived from chemotherapy-treated cancer cell lines can modify angiogenesis
Liu, W M, Dennis, J L, Gravett, A M, Chanthirakumar, C, Kaminska, E, Coulton, G, Fowler, D W, Bodman-Smith, M, Dalgleish, A G
Published in British journal of cancer (28.02.2012)
Published in British journal of cancer (28.02.2012)
Get full text
Journal Article
Seven genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis: a detailed analysis of gene networks and clinical phenotypes
Kerr, J R, Burke, B, Petty, R, Gough, J, Fear, D, Mattey, D L, Axford, J S, Dalgleish, A G, Nutt, D J
Published in Journal of clinical pathology (01.06.2008)
Published in Journal of clinical pathology (01.06.2008)
Get full text
Journal Article
Toxicity profile of the immunomodulatory thalidomide analogue, lenalidomide: Phase I clinical trial of three dosing schedules in patients with solid malignancies
Sharma, R.A., Steward, W.P., Daines, C.A., Knight, R.D., O’Byrne, K.J., Dalgleish, A.G.
Published in European journal of cancer (1990) (01.09.2006)
Published in European journal of cancer (1990) (01.09.2006)
Get full text
Journal Article